Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a multicenter randomized, single-blind, controlled study. The primary objectives of this study are to obtain the pharmacokinetic profile and the relative bioavailability of the INL-001 matrix during and after open hernioplasty compared to Marcaine™ 0.25% infiltration.
Epistemonikos ID: d6e9a2481f3251a709336b84015d66f1aaee99a6
First added on: May 21, 2024